Technical Analysis for MRNA - Moderna, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 107.97 | 1.69% | 1.79 |
MRNA closed up 1.69 percent on Friday, April 26, 2024, on 59 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 2
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
20 DMA Support | Bullish | 1.69% | |
Bollinger Band Squeeze | Range Contraction | 1.69% | |
Gapped Down | Weakness | 1.69% | |
MACD Bullish Signal Line Cross | Bullish | -0.81% | |
Bollinger Band Squeeze | Range Contraction | -0.81% | |
Multiple of Ten Bearish | Other | -0.81% | |
BB Squeeze + Upper Band Touch | Range Contraction | -0.81% |
Alert | Time |
---|---|
Possible NR7 | about 12 hours ago |
Possible Inside Day | about 12 hours ago |
Up 1% | about 16 hours ago |
60 Minute Opening Range Breakdown | 1 day ago |
Fell Below 10 DMA | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: S&P 500 Cancer Life Sciences Biology Nasdaq 100 Vaccines Coronavirus RNA Cancer Vaccine Messenger RNA
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: S&P 500 Cancer Life Sciences Biology Nasdaq 100 Vaccines Coronavirus RNA Cancer Vaccine Messenger RNA
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 142.79 |
52 Week Low | 62.65 |
Average Volume | 3,766,361 |
200-Day Moving Average | 98.61 |
50-Day Moving Average | 102.23 |
20-Day Moving Average | 105.07 |
10-Day Moving Average | 104.99 |
Average True Range | 4.60 |
RSI (14) | 55.75 |
ADX | 14.91 |
+DI | 24.37 |
-DI | 19.39 |
Chandelier Exit (Long, 3 ATRs) | 102.10 |
Chandelier Exit (Short, 3 ATRs) | 110.79 |
Upper Bollinger Bands | 110.39 |
Lower Bollinger Band | 99.75 |
Percent B (%b) | 0.77 |
BandWidth | 10.13 |
MACD Line | 0.94 |
MACD Signal Line | 0.80 |
MACD Histogram | 0.1393 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 112.16 | ||||
Resistance 3 (R3) | 111.77 | 109.98 | 111.46 | ||
Resistance 2 (R2) | 109.98 | 108.91 | 110.17 | 111.23 | |
Resistance 1 (R1) | 108.97 | 108.25 | 109.47 | 109.37 | 111.00 |
Pivot Point | 107.18 | 107.18 | 107.43 | 107.38 | 107.18 |
Support 1 (S1) | 106.18 | 106.11 | 106.68 | 106.57 | 104.94 |
Support 2 (S2) | 104.39 | 105.45 | 104.58 | 104.71 | |
Support 3 (S3) | 103.38 | 104.39 | 104.48 | ||
Support 4 (S4) | 103.78 |